NCT02372110View on ClinicalTrials.gov

Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response

PHASE4CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Anxiety
Interventions
DRUG

HPA, ANS stimulation

Oral administration of Hydrocortisone will increase HPA axis activity. Oral administration of Caffeine will boost ANS activity

DRUG

Placebo

Two cellulose placebo capsules filled with acidophilus powder will be administered to subjects who are randomly assigned to the placebo condition

Trial Locations (1)

78712

University of Texas at Austin, Austin

All Listed Sponsors
lead

University of Texas at Austin

OTHER

NCT02372110 - Disentangling Anxiety Sensitivity and Anxiety-induced Physiological Stress Response | Biotech Hunter | Biotech Hunter